Farnesyltransferase Inhibitor [EPC]

46 reported adverse events

Drugs of this class: LONAFARNIB

These side effects are most commonly reported by patients taking drugs of the Farnesyltransferase Inhibitor [EPC] class:

# Side effect Count
0 PRODUCT DOSE OMISSION ISSUE 14
1 VOMITING 9
2 DIARRHOEA 8
3 NAUSEA 3
4 ABDOMINAL PAIN UPPER 2
5 ANAEMIA 2
6 BREAST CANCER METASTATIC 2
7 CARDIAC ARREST 2
8 DEHYDRATION 2
9 FALL 2
See all common reactions for Farnesyltransferase Inhibitor [EPC]

Drugs of the Farnesyltransferase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GAMMA-GLUTAMYLTRANSFERASE 1 0.0115
1 CARDIAC VENTRICULAR DISORDER 1 0.0032
2 RECTAL PERFORATION 1 0.0025
3 MITRAL VALVE STENOSIS 1 0.0018
4 ELECTROCARDIOGRAM QT CORRECTED INTERVAL PROLONGED 1 0.0013
5 TUMOUR PAIN 1 0.0011
6 CORNEAL ABRASION 1 0.0010
7 EXTRADURAL HAEMATOMA 1 0.0009
8 PRODUCT SUPPLY ISSUE 2 0.0008
9 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0006
See all enriched reactions for Farnesyltransferase Inhibitor [EPC]